Misplaced Pages

electroCore

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
This article is about a medical technology company. For music genres, see Electronicore. Medical technology company in New Jersey

electroCore, Inc. (Nasdaq: ECOR) is a medical technology company based in Basking Ridge, New Jersey. electroCore was co-founded in 2005 by JP Errico, Thomas J. Errico, MD, Charles Theofilos, MD, and Peter Staats, MD. The current chief executive officer is Daniel S. Goldberger. electroCore has one product called gammaCore, a non-invasive, commercially available product that uses vagus nerve stimulation.

History

The company was co-founded by JP Errico, Thomas J. Errico, MD, Charles Theofilos, MD, and Peter Staats, MD, in 2005.

In 2018, electroCore, Inc. went public with a $78 million IPO.

On March 27, 2020, electroCore announced a common stock purchase agreement of up to $25 million with Chicago-based institutional investor Lincoln Park Capital Fund, LLC.

Products

gammaCore Sapphire CV

In July 2020, the FDA gave an emergency COVID-19 authorization for gammaCore Sapphire CV, a vagus nerve stimulation device, aimed at reducing exacerbations in people potentially affected by the novel coronavirus and have difficulty breathing due to asthma.

Truvaga

A VNS product owned by Electrocore.

References

  1. ^ "electroCore Inc. Company & People | ECOR". Barron's. Retrieved 2024-12-12.
  2. "Nerve stimulation device maker electroCore goes public with $78M IPO | FierceBiotech". www.fiercebiotech.com. Retrieved 2019-03-06.
  3. "This hand-held device is approved to treat cluster headaches". NBC News. Retrieved 2019-03-06.
  4. "ElectroCore wins cluster headache FDA 510(k) indication for GammaCore". MassDevice. 2018-11-28. Retrieved 2019-03-06.
  5. "Nerve Stimulator Approved for Cluster Headache". Pain News Network. Retrieved 2019-03-06.
  6. "Term Sheet -- Friday, June 22". Fortune. Retrieved 2019-03-06.
  7. Hale, Conor (2018-06-22). "Nerve stimulation device maker electroCore goes public with $78M IPO | Fierce Biotech". www.fiercebiotech.com. Retrieved 2024-12-16.
  8. "BRIEF-electroCore Announces Common Stock Purchase Agreement For Up To $25 Mln With Lincoln Park Capital". Reuters. 2020-03-27. Retrieved 2020-03-31.
  9. electroCore (2020-07-13). "electroCore Announces FDA Emergency Use Authorization for use of gammaCore Sapphire™ CV for the Acute Treatment of Asthma Exacerbations in Known or Suspected COVID-19 Patients". GlobeNewswire News Room. Retrieved 2020-07-15.
  10. https://www.truvaga.com/vagus-nerve-science/


Stub icon

This United States corporation or company article is a stub. You can help Misplaced Pages by expanding it.

Categories: